First Wave BioPharma
Why Robinhood?
You can watch FWBI and buy or sell other stocks, ETFs, and their options commission-free!About FWBI
Entero Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide.
FWBI Key Statistics
Stock Snapshot
First Wave BioPharma(FWBI) stock is priced at $2.16, giving the company a market capitalization of 3.43M. It carries a P/E multiple of -0.44.
On 2026-05-16, First Wave BioPharma(FWBI) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for First Wave BioPharma(FWBI) stock has reached 0, versus its average volume of 204.95K.
Over the past 52 weeks, First Wave BioPharma(FWBI) stock has traded between a high of $5.84 and a low of $0.97.
Over the past 52 weeks, First Wave BioPharma(FWBI) stock has traded between a high of $5.84 and a low of $0.97.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.